To conduct patient-directed research that elucidates the molecular mechanisms driving disease pathology and symptoms through continuous scientific exchange between clinicians and scientists, followed by meaningful collaborations with biopharma partners.
The research journey at Narayana Nethralaya began with a simple idea: using patient insights to drive scientific progress. Its large patient base provided rich clinical data to inform early diagnosis, prevention, and the development of innovative therapies—laying the foundation for the Narayana Netralaya Foundation's research ecosystem.
The Narayana Netralaya Foundation established its first basic research team to bridge laboratory science with clinical care. The team focused on patient-directed research, using real clinical data to drive their scientific inquiries. Their goal was to enhance early diagnosis, improve prevention, and develop more effective therapies, ensuring that research was always grounded in clinical relevance.
GROW (Genes, Repair and Regeneration in Ophthalmic Workstation) was established to bridge laboratory research and clinical application. It focuses on understanding the molecular and genetic mechanisms underlying eye diseases, using in vitro and in vivo preclinical models. The lab also develops gene and stem cell therapy platforms while identifying biomarkers and potential therapeutic targets.
As research progressed, clinical data informed new lines of enquiry. Laboratory findings were validated using patient datasets, strengthening the preclinical foundation for future clinical translation. This cyclical approach established a robust model of patient-informed research.
Alongside GROW, the IBMS (Imaging, Biomechanics and Mathematical Modelling Solutions) lab expanded the research ecosystem. It investigates structural and functional changes in ocular tissues using advanced imaging technologies and image-processing algorithms. Its work spans both anterior and posterior segments of the eye, employing tools such as ultra-widefield fundus imaging, adaptive optics, and dynamic vascular imaging.
Today, GROW and IBMS have positioned Narayana Nethralaya as a centre for patient-driven research, clinical collaboration, and technological innovation—advancing diagnostics, therapeutic development, and future clinical translation
The research and clinical teams at nVision bring together highly qualified, experienced, and passionate professionals across their fields. With advanced degrees from leading institutions and expertise spanning ophthalmology and biomedical science, our faculty and researchers are united by a shared commitment to advancing human health. They apply their knowledge, focus, and innovation to addressing complex eye diseases and translating discoveries into real-world impact. Their collective efforts drive scientific excellence, enable breakthrough research, and further our mission to improve vision and quality of life for patients worldwide.
At nVision, the pursuit of excellence is recognised and celebrated across clinical care, scientific research, education, and innovation. Our faculty, researchers, and clinicians have received prestigious awards and honours at national and international levels for their contributions to research, clinical leadership, and academic distinction—reflecting the depth of talent and commitment within our community.
These recognitions underscore our dedication to advancing ophthalmic science, improving patient outcomes, and driving meaningful impact in human health and healthcare delivery.
Narayana Netralaya Foundation upholds a strict code of ethics, with policies regularly reviewed and updated to align with international standards for privacy, transparency, and governance. Please click below to view our full policy statement.